Li, Xin
Sun, Feifei
Zhang, Xiaolei
Lin, Pingping
Shen, Kai
Shen, Yu
Ma, Lingyu
Cao, Yu
Wang, Chenjing
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Article History
Received: 24 August 2022
Accepted: 13 March 2023
First Online: 3 April 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice Guideline. Study protocol and all amendments were approved by the independent ethics committee of the Affiliated Hospital of Qingdao University (approval number: QYFYEC 2020–068-01). All subjects provided written informed consent before enrollment.
: Not applicable.
: Kai Shen, Yu Shen, and Lingyu Ma are employees of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Other co-authors declare no competing interests.